Pilot Launch You have early access to the Barinhall Compliance Intelligence Portal. Coverage and features are expanding weekly. Share feedback →
← Back to Feed
View source document ↗
T4 SEC Medium Confidence Proposed Rule

SEC Proposes Amendments to Exchange Act Rule 15c2-11

Regulatory clarity and scope clarification for OTC equity market quotations

MINIMAL
Impact Level
Top: compliance (2)

Advisory Assessment

Impact. This proposed amendment narrows Rule 15c2-11's scope to equity securities only, codifying what most broker-dealers already understand about the rule's application. Your current OTC quotation practices for non-equity securities will no longer fall under this rule's information-gathering requirements, though anti-manipulation provisions remain unchanged.

Risk. The primary exposure lies in misunderstanding the scope change during the transition period, particularly for trading desks that handle mixed OTC portfolios. Examination staff may test whether your firm correctly distinguishes between equity and non-equity OTC quotation requirements once finalized.

Recommended Action. Have your Legal team review current OTC quotation procedures to identify any over-compliance with Rule 15c2-11 for non-equity securities. Trading should document which securities currently trigger Rule 15c2-11 reviews to ensure clean implementation when the amendment becomes effective.

Watch. Monitor the 60-day comment period for industry pushback that might reshape the final rule's scope. Track the final rule's effective date since your quotation systems and compliance procedures will need updates to reflect the narrowed application.

Classification

Regulatory Program
Exchange Act Rule 15c2-11
Doc Type
Proposed Rule
Effective Date
Date not stated
Days to Action
Comment Deadline
Published

Urgency Basis

Proposed rule with 60-day comment period, no immediate effective date

Operational Context

Flags
Legal Review Required
Affected Functions
Trading Compliance Legal
Institution Applicability
Broker-Dealers Market Makers Otc Market Participants

Impact by Category

Compliance
2
Operational
1
Data Governance
0
Model Risk
0
Reporting & Disclosure
1
Capital & Liquidity
0
Consumer Protection
1
Third-Party Risk
1

Key Requirements

- Apply Rule 15c2-11 requirements only to equity securities - Maintain existing information gathering requirements for OTC quotations - Continue compliance with anti-manipulation provisions - Review current practices for non-equity OTC securities

Scoring Rationale

This is a clarifying amendment that narrows the scope of Rule 15c2-11 to equity securities only. The change codifies existing market understanding and practice rather than imposing new substantive requirements. Impact is minimal across most categories as this represents regulatory housekeeping rather than fundamental policy change.

Scored: 2026-05-16T17:37:08.982Z Model: claude-sonnet-4-20250514 Confidence: Medium Aggregate Score: 1.0
AI Analysis Disclosure — This record, including its scores, impact assessments, and Advisory Assessment (impact, risk, and recommended actions), was generated by an AI model and may contain errors or omissions. The Advisory Assessment is a starting point for analysis, not a substitute for professional judgment. Effective dates, applicability determinations, impact assessments, and any recommended actions should be independently verified against primary regulatory source documents and reviewed by qualified compliance or legal personnel before taking compliance action. This output does not constitute legal or compliance advice.